Stella Pharma Corp. Hits Day High with Strong 7.31% Intraday Surge

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant uptick in its stock performance today, gaining 7.31% as of April 8, 2026. The stock reached an intraday high of JPY 698.00, reflecting a strong day of trading activity. In terms of performance metrics, Stella Pharma Corp. has shown impressive year-to-date growth of 239.9%, significantly outperforming the Japan Nikkei 225, which has risen by 11.86% during the same period. Over the past year, the stock has delivered a remarkable return of 118.35%, again surpassing the Nikkei's 70.57% increase. However, the company has faced challenges, including a negative EBITDA of Rs. -55.52 crore and a low return on equity of -6.21%, indicating ongoing financial difficulties. Despite these hurdles, the stock's recent performance highlights its volatility and the potential for movement within the market. Investors and market watchers will be keen to observe how Stella Pharma Corp. navigates its current financial landscape in the coming days.